Press releases | Medtronic (Neuroscience Portfolio) https://news.medtronic.com/ Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain https://news.medtronic.com/2026-07-16-Medtronic-completes-acquisition-of-SPR,-expanding-patient-access-to-minimally-invasive,-non-opioid-treatment-of-chronic-and-acute-pain Thu, 16 Jul 2026 09:00:00 -0400 https://news.medtronic.com/2026-07-16-Medtronic-completes-acquisition-of-SPR,-expanding-patient-access-to-minimally-invasive,-non-opioid-treatment-of-chronic-and-acute-pain Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care https://news.medtronic.com/2026-06-12-Medtronic-completes-acquisition-of-Scientia-Vascular,-seamlessly-integrating-access-and-therapeutic-portfolios-for-neurovascular-care Fri, 12 Jun 2026 11:00:00 -0400 https://news.medtronic.com/2026-06-12-Medtronic-completes-acquisition-of-Scientia-Vascular,-seamlessly-integrating-access-and-therapeutic-portfolios-for-neurovascular-care Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain https://news.medtronic.com/2026-05-20-Medtronic-announces-intent-to-acquire-SPR-Therapeutics,-Inc-,-expanding-care-options-for-people-living-with-chronic-pain Wed, 20 May 2026 09:15:00 -0400 https://news.medtronic.com/2026-05-20-Medtronic-announces-intent-to-acquire-SPR-Therapeutics,-Inc-,-expanding-care-options-for-people-living-with-chronic-pain Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures https://news.medtronic.com/2026-03-27-Medtronic-Receives-FDA-Clearance-for-Stealth-AXiS-TM-Surgical-System-for-Cranial-and-ENT-Procedures Fri, 27 Mar 2026 09:00:00 -0400 https://news.medtronic.com/2026-03-27-Medtronic-Receives-FDA-Clearance-for-Stealth-AXiS-TM-Surgical-System-for-Cranial-and-ENT-Procedures Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain https://news.medtronic.com/2026-03-24-Medtronic-and-Merit-Medical-Systems-enter-into-agreement-to-offer-new,-FDA-cleared-ViaVerte-TM-system,-a-basivertebral-nerve-ablation-treatment-for-chronic-vertebrogenic-lower-back-pain Tue, 24 Mar 2026 08:30:00 -0400 https://news.medtronic.com/2026-03-24-Medtronic-and-Merit-Medical-Systems-enter-into-agreement-to-offer-new,-FDA-cleared-ViaVerte-TM-system,-a-basivertebral-nerve-ablation-treatment-for-chronic-vertebrogenic-lower-back-pain